In 2023, there were approximately ****** food poisoning cases caused by food and water borne diseases reported in Malaysia. Meanwhile, there were *** cases of dysentery and ** cases of cholera recorded in the same year.

Cause of death, by non-communicable diseases (% of total) in Malaysia was reported at 73.44 % in 2019, according to the World Bank collection of development indicators, compiled from officially recognized sources. Malaysia - Cause of death, by non-communicable diseases (% of total) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

This dataset shows the Number Of Deaths By Type Of Diseases, Malaysia, 2000 - 2016.Footnote p - preliminary Source : Ministry of Health, Malaysia

This dataset shows the Number Of Cases And Incidence Rate (Per 100,000 Population) Of communicable Diseases, Malaysia, 2000 - 2021. Footnote: Incidence rate is per 100,000 population Source : Ministry of Health, Malaysia No. of Views : 533

Comprehensive dataset of 13 Infectious disease physicians in Malaysia as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

This line chart displays deaths (people) by date using the aggregation sum in Malaysia. The data is filtered where the disease is Mpox. The data is about diseases per day.

In 2022, approximately 209 measles cases were reported in Malaysia, a disease which could have been prevented by vaccines. Meanwhile, the country recorded 101 pertussis cases in the same year.

Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total) in Malaysia was reported at 18.14 % in 2019, according to the World Bank collection of development indicators, compiled from officially recognized sources. Malaysia - Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

This dataset shows the Number Of Cases Of Communicable Diseases By Type Of Diseases, Malaysia, 2000 - 2021. Source: Ministry of Health, Malaysia No. of Views : 583

Communicable diseases of Malaysia slumped by 9.09% from 22.0 % in 2000 to 20.0 % in 2012. Since the 9.09% drop in 2012, communicable diseases remained constant by 0.00% in 2012.

In 2023, pneumonia was the leading cause of death in Malaysia, with more than ****** recorded cases. This was followed by ischaemic heart diseases, with around ****** deaths resulted from this disease.

This line chart displays cases (people) by date using the aggregation sum in Malaysia. The data is filtered where the disease is Mpox. The data is about diseases per day.

COVID-19 data for Malaysia from 2020-01-25 to 2023-11-04, including beds_icu_covid, daily_full, daily_partial, hosp_covid, icu_covid, tot_cases, tot_deaths

Files:

• ".pkl" Cache file backup
• Dataframe exported "PyCoa-DF.csv"
• Original database backup

This dataset contains data from WHO's data portal covering the following categories:

Adolescent, Ageing, Air pollution, Assistive technology, Child, Child mortality, Cross-cutting, Dementia diagnosis, treatment and care, Environment and health, Foodborne Diseases Estimates, Global Dementia Observatory (GDO), Global Health Estimates: Life expectancy and leading causes of death and disability, Global Information System on Alcohol and Health, Global Patient Safety Observatory, Global strategy, HIV, Health financing, Health systems, Health taxes, Health workforce, Hepatitis, Immunization coverage and vaccine-preventable diseases, Malaria, Maternal and newborn, Maternal and reproductive health, Mental health, Neglected tropical diseases, Noncommunicable diseases, Nutrition, Oral Health, Priority health technologies, Resources for Substance Use Disorders, Road Safety, SDG Target 3.8 | Achieve universal health coverage (UHC), Sexually Transmitted Infections, Tobacco control, Tuberculosis, Vaccine-preventable communicable diseases, Violence prevention, Water, sanitation and hygiene (WASH), World Health Statistics.

For links to individual indicator metadata, see resource descriptions.

The data is daily data recorded from 1 January 2009 to 28 December 2019. The dataset include the number of confirmed cases of HFMD for respective regions (East Coast, Borneo, Central, Northern, Southern) in Malaysia. The explanatory data such as temperature (temp), rainfall (r), and relative humility (rh) are provided.

Malaysia Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 20.100 NA in 2016. This records a decrease from the previous number of 20.300 NA for 2015. Malaysia Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 21.200 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 22.800 NA in 2000 and a record low of 20.100 NA in 2016. Malaysia Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Malaysia – Table MY.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Top 10 rare diseases in Malaysia, number of patients, number of patients treated and its treatments.

In Malaysia Ischemic Heart Disease Market, It has experienced significant growth in recent years due to the rising prevalence of cardiovascular diseases, changing lifestyle factors, and advancements in diagnostic and therapeutic technologies.

The Malaysia Genetic Disease Diagnosis Market is positioned for continued expansion, driven by technological innovations and a commitment to enhancing public health.

Objectives: This study assesses the opinions of health professionals in Malaysia on the disruption of non-communicable disease (NCD) services during the COVID-19 pandemic from March 2020 to January 2022.Methods: We conducted a cross-sectional online survey with 191 non-clinical public health workers and clinical health service workers in Malaysia from November 2021 to January 2022. Participants were recruited by the Malaysian Ministry of Health using major networks including key experts and practitioners. Secondary respondents were subsequently enrolled through snowballing.Results: The most notable issues raised by the survey participants relate to NCD service disruption, the redirection of NCD care resources, and NCD care being overburdened post-pandemic. Respondents also reported accounts of resilience and prompt reaction from the healthcare system, as well as calls for innovation.Conclusion: Most respondents perceived that the challenges arising from COVID-19 were mostly managed well by the healthcare system, which was able to provide the necessary services to NCD patients during this health emergency. However, the study identifies gaps in the health system response and preparedness capacity, and highlights solutions for strengthening NCD services.